ABSTRACT
M
S is an inflammatory demyelinating and neurodegenerative disease of the CNS. Differentiating MS lesions, especially chronic lesions, may provide a biomarker for disease progression and a therapeutic target to reduce ongoing tissue damage. A subset of chronic lesions, identified as chronic active or slowly expanding lesions, have been described as having a rim of iron-enriched proinflammatory activated microglia and macrophages. [1] [2] [3] [4] Iron-enriched proinflammatory microglia release cytotoxins to adjacent oligodendrocytes, 5 limit remyelination, and contribute to further demyelination in chronic active lesions. 3 Therefore, identifying MS lesions with iron accumulation may enable the prediction of tissue damage.
MR imaging with a gradient-echo (GRE) sequence is sensitive to iron 1, 6 and has been explored by many investigators to detect an iron rim in chronic active MS lesions. 1, 3, 4, [7] [8] [9] Iron may be detected as hypointensity on a T2
* -weighted GRE magnitude image or its phase-enhanced version known as SWI. 8, 10 An R2 * (ϭ 1 Ϭ T2 * ) map computed from a multiecho GRE magnitude image can be used to estimate iron content. 11 Unfortunately, precise mapping of iron location by these magnitude-based approaches is hindered by blooming artifacts, particularly at high iron concentrations. 12 Alternatively, the local magnetic field derived from a GRE phase image has been studied to quantify iron. 13, 14 However, because the local phase is affected by magnetic sources in the surrounding tissue, the phase pattern may not represent the true magnetic susceptibility pattern. 15 Quantitative susceptibility mapping (QSM) 16 is a phase-based magnetic field deconvolution technique that overcomes the blooming artifacts and provides more accurate quantification and localization of the magnetic sources. 17, 18 QSM has been established as a more sensitive and quantitative technique for measuring brain iron compared with T2 * , R2, and R2 * . 19, 20 Studies have emerged combining QSM with additional MR tissue parameters, such as R2 * , to characterize the pattern of iron deposition and demyelination among various MS lesions. [21] [22] [23] However, the interpretation of iron accumulation and the associated tissue damage can be complicated because QSM and R2 * are both sensitive to iron and myelin. Moreover, accurate tracking of lesion susceptibility changes over time is hindered by the lack of a reliable susceptibility reference, given that CSF can often appear highly heterogeneous on QSM and normalappearing white matter may undergo pathologic iron or myelin changes.
14 This study aimed to address these challenges by combining 2 recently developed techniques: myelin water fraction (MWF) imaging by using fast acquisition with spiral trajectory and T2-prep (FAST-T2) 24, 25 and QSM with automatic uniform CSF zero ref-
. MWF is a well-validated quantitative MR imaging biomarker for myelin, 26, 27 which can be mapped efficiently and reproducibly with FAST-T2. 25, 28 The QSM0 algorithm improves QSM zero reference selection by enforcing the susceptibility homogeneity of CSF within the brain ventricles and eliminating the need for manual drawing of CSF ROIs. QSM0 and MWF were used to identify MS lesions with a hyperintense rim pattern consistent with iron deposition and to assess the extent of myelin damage found within these lesions.
MATERIALS AND METHODS

Patient Population
This was a retrospective study of 
MR Imaging Postprocessing
Brain QSM0 maps were reconstructed from multiecho GRE data by using the morphology-enabled dipole inversion method 29, 30 and incorporating automated segmentation and regularization specific to CSF. Briefly, CSF within the lateral ventricles was identified by thresholding of the R2 * map (R2 * Ͻ 5 seconds Ϫ1 ) and imposing voxel connectivity. A regularization term penalizing susceptibility variation within the CSF mask was incorporated into the morphology-enabled dipole inversion algorithm to search for a solution with homogeneous CSF susceptibility. MWF maps were reconstructed from FAST-T2 data by using a multivoxel nonlinear least-squares data-fitting algorithm with spatial smoothness constraints. 25 The lower and upper T2 bounds for each of the 3 water pools (in milliseconds) were set to [5 20] , [20 200 ], and [200 2000], respectively (corresponding to myelin water, intra-and extracellular water, and long-T2 water such as CSF). MWF was calculated as the ratio of the myelin water signal and the total water signal within a voxel. Anatomic images and MWF maps were coregistered to GRE magnitude images (and the associated QSM maps) by using the FMRIB Linear Image Registration Tool (FLIRT; https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLIRT) algorithm.
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Image Analysis
Two neuroradiologists (Y.Z. and Y.Y) with 6 and 4 years of experience, respectively, independently reviewed all images. First, MS lesions were identified and manually traced on T2-weighted images. Only gadolinium-negative lesions were considered in the primary analysis. Lesions were identified as rim-positive (rimϩ) or rimnegative (rimϪ) based on the consensus of both reviewers regarding their visual appearance on QSM obtained at each time point (QSM1 and QSM2). In the case of a disagreement, a third neuroradiologist (I.K.) with 20 years of experience was called on to determine the lesion subtype. Next, ROI analysis was performed by using ITK-SNAP software (version 3.2; http://www.itksnap.org/) to obtain regional QSM measurements within the identified lesions. ROIs were traced on QSM and MWF for the whole lesion by using the T2-weighted lesion ROI as a starting point, with additional manual adjustments if needed. Central veins, identified as vessel-like structures with a hyperintense QSM appearance, were manually removed from QSM ROIs. In addition, for rimϩ lesions, the lesion core (defined as the part of the lesion that extends from the center to the inner boundary of the hyperintense QSM rim) was traced on QSM and then transferred to MWF maps and manually edited if necessary. Lesion rim ROI was defined as the ROI difference between the whole lesion and the lesion core.
Statistical Analysis
Mixed-effects models were implemented to assess the variables of interest (lesion QSM and MWF values) among rimϩ and rimϪ lesions. The modeling strategy accounts for multiple lesions per patient and repeated measurements (longitudinal analysis), and the following covariates were always considered: patient age, sex, T2-weighted lesion volume, and time interval between MRIs. The final model is reported after using a back-fitting procedure set at ␣ ϭ 0.10 for inclusion. The mean QSM and MWF values within the lesion core and rim areas of rimϩ lesions were compared by a paired t test.
RESULTS
Identification of QSM Rim؉ and Rim؊ Lesions
All T2-weighted hyperintense lesions that were present at both time points were reviewed and considered chronic if they were not enhancing with gadolinium. Two lesions were excluded because of a subthreshold volume (Ͻ14 mm 3 ), and 15 lesions were excluded because of image artifacts and poor QSM quality. The remaining lesions included 116 rimϩ lesions from 35 of 46 patients with MS (34 relapsing-remitting and 1 secondary-progressive) and 441 rimϪ lesions from 42 of 46 patients with MS (1 clinically isolated syndrome, 40 relapsing-remitting, and 1 secondary-progressive). Most patients (31 of 46) were found to have both rimϩ and rimϪ lesions. Of the patients having 1 lesion subtype, 4 of 15 had only rimϩ lesions and the remaining patients (11 of 15) had only rimϪ lesions. Ten patients had gadolinium-enhancing lesions at any time point (12 lesions). The clinical characteristics (ie, disease duration or Expanded Disability Status Scale score) between the 2 groups of patients having only 1 lesion subtype were similar. Among all the patients, there was no significant correlation between the number of rimϩ lesions and disease duration (P ϭ .43). Figure 1 shows an example of T2-weighted images and corresponding QSM from 2 patients with relapsing-remitting MS, illustrating the appearance of rimϩ and rimϪ lesions on QSM (4 additional patient examples are shown in On-line Fig 1) . For whole lesion ROI, QSM1 of rimϩ lesions and rimϪ lesions were 6.0 Ϯ 14.4 parts per billion (ppb) and Ϫ7.0 Ϯ 17.1 ppb, respectively (On-line Fig 2) . There was no significant difference between the patient age among the rimϩ and rimϪ lesion subgroups (44.1 Ϯ 10.6 versus 43.5 Ϯ 10.7; P ϭ .82), and the Expanded Disability Status Scale score was similar among the lesion subtype groups (P ϭ .80). After accounting for patient variability as a random effect (mixed-effects model), the QSM1 values in rimϩ lesions were on average 6.8 ppb higher than those in rimϪ lesions (P Ͻ .001). There was no significant association found with T2-weighted lesion volume, sex, or patient age.
Comparison of QSM Rim؉ and Rim؊ Lesions
Longitudinal Assessment of QSM Classification
QSM classification at follow-up MR imaging predominantly remained the same. All rimϩ lesions retained the hyperintense rim at both time points (QSM1 and QSM2). Three lesions were initially identified as rimϪ at QSM1 and demonstrated a positive hyperintense rim at QSM2. T2 lesion volume remained stable between the 2 longitudinal MR imagings for both rimϩ (P ϭ .94) and rimϪ (P ϭ .07) lesions. Rimϩ lesions demonstrated an increase in whole-lesion QSM (4.8 Ϯ 10.3 ppb) over time, with both the core and rim ROI values increasing by 4.0 Ϯ 11.6 ppb and 5.3 Ϯ 11.0 ppb, respectively. QSM values for rimϪ lesions also increased over time, but with smaller differences (2.3 Ϯ 10.8 ppb). A mixed-effects model confirmed a significant change in QSM values within the rim (P Ͻ .001) and core (P Ͻ .001) regions of rimϩ lesions.
QSM and MWF Assessment of Lesions
At the second time point, QSM and MWF values within the rim and core regions of rimϩ lesions were examined to support the premise that iron is present at the lesion edge. The volumes of the rim and core area were 271.4 Ϯ 200.9 mm 3 and 116.6 Ϯ 113.7 mm 3 , respectively. There was a centripetal pattern of reduction observed in both QSM and MWF. In rimϩ lesions, the mean QSM value significantly decreased from the rim (13.3 Ϯ 16.3 ppb) to the core (5.9 Ϯ 15.2 ppb; P Ͻ .01; Fig 2) . As with QSM, the rimϩ lesions demonstrated a significant decrease of MWF from the rim (0.052 Ϯ 0.022) to the core (0.039 Ϯ 0.022; P Ͻ .01; Fig 2) .
MWF whole-lesion values for rimϩ lesions were lower compared with rimϪ lesions (0.055 Ϯ 0.070 and 0.066 Ϯ 0.040, respectively; Fig. 3 ) and found to be consistently lower with the exclusion of patients with gadolinium-enhancing lesions (0.044 Ϯ 0.021 and 0.068 Ϯ 0.040, respectively; On-line Fig 3) . This difference became more obvious in the mixed-effects model, which showed that whole-lesion MWF in rimϩ lesions was on average 0.01 (Fig 3) lower compared with rimϪ (P Ͻ .001). A similar difference in MWF (0.011; P Ͻ .001) was found with the exclusion of patients with gadolinium-enhancing lesions (On-line Fig 3) . T2-weighted lesion volume remained a significant covariate in the final model (P Ͻ .001). For every cubic millimeter increase in T2-weighted volume, MWF decreased by 0.000013. The MWF differences among rimϩ and rimϪ lesions can be appreciated on the MWF map shown in Fig 4. In rimϩ lesions, we further expanded our analysis to explore the specific relationship of the hyperintense rim at the first time point (susceptibility value and volume on QSM1) and subsequent MWF. In the mixed-effects model, the volume of the rim at QSM1 (P Ͻ .01) was the only significant covariate; for every cubic millimeter increase in QSM1 rim volume, lesion MWF decreased by 0.00002. Figure 5 highlights the MWF differences between thick rim and thin rim lesions.
DISCUSSION
Our study is one of many demonstrating that GRE MR imaging can identify a discrete subset of chronic MS lesions, 1, 3, 4, [7] [8] [9] and as with other studies, we demonstrate the retention of the iron rim and more tissue damage in these selected lesions. There are 3 unique components to our study: 1) the application of QSM0 for a more accurate identification and quantification of iron rim lesions in a longitudinal study, compared with conventional QSM, SWI, or MR phase; 2) a multitechnique approach of combining QSM with a myelin-specific MR imaging acquisition (MWF); and 3) quantitatively examining the susceptibility and myelin content within the individual components of QSM hyperintense rimϩ lesions (rim and core regions). Our work provides further in vivo evidence that GRE MR imaging can identify chronic lesions with more demyelination, which is consistent with the known histopathologic classification of a chronic active MS lesion.
QSM studies of MS lesions have uncovered interesting dynamics wherein lesion susceptibility substantially increases shortly after gadolinium enhancement and remains high for the first few years. 32, 33 The susceptibility increase in MS lesions can come from demyelination and/or iron accumulation. 17 The integrated multitechnique QSMϩMWF approach described in this study allows for a novel quantitative investigation of the connection between iron-associated inflammation and tissue damage in the brains of patients with MS. Recent patient studies demonstrated increased tissue damage on T1-weighted images for MS lesions with a persistent rim on phase images 4 and a higher occurrence of lesions with a QSM rim in patients with progressive MS and increasing disability. 23 However, it is difficult to quantify tissue damage on T1-weighted hypointensity. In addition, studies using QSM and R2 * described QSM hyperintense rim lesions as having minor myelin loss compared with other lesion subtypes, 22 which is inconsistent with the histopathologic description of chronic active lesions as having extensive demyelination 34 ; this discrepancy may be the consequence of R2 * being influenced by iron. For a quantitative assessment of tissue damage in white matter MS lesions, MWF is regarded as an indirect measure of myelin with a relatively high specificity given the strong pathologic correlation. [26] [27] [28] We recognize that an increase of susceptibility within a chronic lesion can be due to demyelination or iron deposition, which limits direct iron quantification by QSM. 17 We identify QSM rimϩ lesions as having a rim of iron based upon the susceptibility gradient between the rim and core regions. Support of this approach is based upon 3 factors: 1) a known pattern of demyelination found within chronic active MS lesions (attenuated loss of myelin in core) 3, 6, 12 ; 2) histologic studies demonstrating that GRE can detect iron within activated microglia and macrophages at the edge of chronic active MS lesions 1, 3, 4, 11, 14, 15 ; and 3) our own data, demonstrating a decrease in both susceptibility and MWF from rim to core, which can only be explained by iron deposition. Thus, we conclude that iron is contributing, at least in part, to the signal at the rim, but importantly, we are not quantifying the absolute extent that iron or myelin is contributing to the QSM signal. This QSMϩMWF study helps highlight the clinical importance of chronic active lesions, which have been largely ignored in current clinical practice, but may potentially be treated to reduce tissue damage and possibly slow disease progression as suggested by clinical and immunohistologic data. After the acute stage, a significant increase in both QSM and R2 * occurs in lesions that are no longer enhancing, yet under 1 year of age, suggesting that iron release occurs during the early stages after myelin destruction. 21 These findings are consistent with the release of iron secondary to myelin and oligodendrocyte destruction 9, 35 and provide a source for iron-laden proinflammatory microglia and for iron-driven amplification of oxidative stress within the acute MS lesion. 2, 36 Studies have shown evidence for oxidative stress damage to oligodendrocytes and mitochondrial and dystrophic axons in acute MS lesions, 37 which consequently inhibit endogenous remyelination.
Correspondingly, we found that lesions having a QSM hyperintense rim had a significantly lower MWF throughout the whole lesion compared with those identified as without rim. Interestingly, we found an association with rim volume and lesion MWF, which is consistent with thicker-rimmed chronic lesions demonstrating more active demyelination.
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Chronic active MS lesions have been found to be more prominent in progressive disease compared with the relapsing stage of the disease, and their continued expansion may play an essential role in the pathogenesis of progressive disease. 38 In vivo imaging studies of phase or QSM have revealed conflicting results regarding the prevalence of rimϩ lesions among patients with MS. 39 One previous study demonstrated a vast difference among QSM and phase results, wherein the authors concluded that QSM was superior to the depiction of spatial susceptibility patterns in MS lesions. 15 Similarly, we found wide-ranging differences in lesion classification based upon QSM versus phase images (data not shown). A major contributing factor to the difficulty of identifying and quantifying rimϩ lesions has been the choice of susceptibility reference tissue. Wiggerman et al 35 have recently demonstrated in postmortem samples that lesion phase and QSM contrast can be highly influenced by pathologic alterations in myelin and iron in normal-appearing white matter, a typical choice of QSM reference in MS lesion studies. CSF being 99% pure water is another common choice of susceptibility reference; however, current QSM reconstruction algorithms often produce a highly inhomogeneous CSF appearance in the brain ventricles, most likely due to the susceptibility anisotropy effect of the adjacent brain white matter. Consequently, the zero reference in previous studies often depends on the manual selection of ROI, making it less suited for longitudinal studies. A unique component of our study was the use of QSM0, a recently developed QSM inversion method that automatically selects a CSF mask based on R2 * derived from a GRE magnitude image and enforces uniformity within the CSF region. This improvement could lead to better detection and quantification of QSM lesions. Interestingly, the current study population is predominantly relapsing patients with minimal disability and differs significantly from postmortem studies, which generally lack the inclusion of younger patients. Therefore, to determine the true prevalence and incidence of these lesions among patients with MS, future studies will require a consistent imaging protocol, for which we favor QSM0, on a larger cohort of patients that includes both relapsing and progressive stages of the disease. In addition, QSM and MWF provides an opportunity to further explore the range of myelin damage of these particular lesions, especially those found in younger MS patients. This study has several limitations. First, our analysis is limited by the incomplete longitudinal design due to MWF only being acquired at the second time point. Further studies evaluating the longitudinal relationship of QSM and MWF in acute MS lesions will improve our understanding of the complex association of lesion iron deposition and myelin damage. Although our results of combining the data from QSM and MWF provide support for iron deposition, we lack histologic validation that lesions demonstrating a hyperintense rim on QSM truly have iron deposition; however, a number of mentioned studies have validated GRE imaging to identify these lesions. Further highlighting the necessity of histopathologic validation is that paramagnetic iron is generally expected to shorten the T2 relaxation time of brain tissue, and the resulting effect on the accuracy of MWF quantification is currently not well understood. Therefore, MWF measurements in QSM rimϩ lesions in the presence of elevated iron should be interpreted with caution. Last, clinical factors, such as specific treatments or medication changes, were not considered as variables of interest in our analysis. Treatment duration was the only "treatment-related" variable included in the mixed-effects models because of the complexity of individual patient management decisions. Our analysis presumes that specific MS treatments have no influence on the lesions' iron or myelin content, and we recognize that this may be a limitation; however, there is no current evidence to contradict this assumption. Furthermore, larger stud-
